Benedicte Huberlant

Suggest Changes
Learn More
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo-controlled(More)
  • 1